SightGlass Vision studies find DOT spectacle lenses as highly effective for myopia management, show no evidence of rebound

Published on May 2, 2025
The CATHAY trial evaluated 186 myopic children, 6 to 13 years old at initiation, across 5 hospitals.
Continue reading on website
Other news

Peripapillary BMO-MRW Significantly Reduced in Early DR

May 2, 2025
The combination of BMO-MRW and OCT-A-derived microvascular metrics could potentially serve as early biomarkers for DR detection and progression monitoring. Photo: Julie Torbit, OD. Click image to enlarge. Studies have shown that retinal neurodegeneration takes place before microvascular changes are detected in diabetic retinopathy (DR) patients. Bruch’s membrane opening-mini

ARVO 2025: New research reveals new marker for presbyopic accommodation

May 2, 2025
While the study included a range of subjects in a variety of stages of presbyopia, the change in crystalline lens geometry and anterior segment was most pronounced in emmetropic and myopic presbyopes.